While certain cancer types (ie, HNC and HPBC) exhibited a higher rate of TERT promoter mutations in primary tumor samples compared to metastatic samples, mutations were more prevalent in metastatic samples of melanoma and thyroid cancer compared to primary tumors. The gene discussed is TERT; the disease is cancer.